Xu L - Search Results

1

Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial.

Oelke M, Giuliano F, Mirone V, Xu L, Cox D, Viktrup L. Oelke M, et al. Among authors: xu l. Eur Urol. 2012 May;61(5):917-25. doi: 10.1016/j.eururo.2012.01.013. Epub 2012 Jan 20. Eur Urol. 2012. PMID: 22297243 Clinical Trial.

2

Likelihood of tadalafil-associated adverse events in integrated multiclinical trial database: classification tree analysis in men with erectile dysfunction.

Brock G, Glina S, Moncada I, Watts S, Xu L, Wolka A, Kopernicky V. Brock G, et al. Among authors: xu l. Urology. 2009 Apr;73(4):756-61. doi: 10.1016/j.urology.2008.10.058. Epub 2009 Feb 4. Urology. 2009. PMID: 19193420

3

Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.

Dmochowski R, Roehrborn C, Klise S, Xu L, Kaminetsky J, Kraus S. Dmochowski R, et al. Among authors: xu l. J Urol. 2010 Mar;183(3):1092-7. doi: 10.1016/j.juro.2009.11.014. Epub 2010 Jan 25. J Urol. 2010. PMID: 20092847 Clinical Trial.

4

Urodynamic standardization in a large-scale, multicenter clinical trial examining the effects of daily tadalafil in men with lower urinary tract symptoms with or without benign prostatic obstruction.

Kraus SR, Dmochowski R, Albo ME, Xu L, Klise SR, Roehrborn CG. Kraus SR, et al. Among authors: xu l. Neurourol Urodyn. 2010 Jun;29(5):741-7. doi: 10.1002/nau.20825. Neurourol Urodyn. 2010. PMID: 20151469 Clinical Trial.

5

Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial.

Porst H, Kim ED, Casabé AR, Mirone V, Secrest RJ, Xu L, Sundin DP, Viktrup L; LVHJ study team. Porst H, et al. Among authors: xu l. Eur Urol. 2011 Nov;60(5):1105-13. doi: 10.1016/j.eururo.2011.08.005. Epub 2011 Aug 12. Eur Urol. 2011. PMID: 21871706 Clinical Trial.

6

Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.

Dmochowski R, Roehrborn C, Klise S, Xu L, Kaminetsky J, Kraus S. Dmochowski R, et al. Among authors: xu l. J Urol. 2013 Jan;189(1 Suppl):S135-40. doi: 10.1016/j.juro.2012.11.025. J Urol. 2013. PMID: 23234619 Clinical Trial.

7

Tadalafil once daily in the treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in men without erectile dysfunction.

Brock G, Broderick G, Roehrborn CG, Xu L, Wong D, Viktrup L. Brock G, et al. Among authors: xu l. BJU Int. 2013 Nov;112(7):990-7. doi: 10.1111/bju.12251. Epub 2013 Aug 13. BJU Int. 2013. PMID: 23937669 Clinical Trial.

8

Robot-assisted radical prostatectomy using a novel urethral reconstruction technique vs standard vesicourethral anastomosis. A retrospective cohort study.

Qi W, Dou M, Xu L, Qu S, Zhu Y, Chen S, Shi B. Qi W, et al. Among authors: xu l. World J Urol. 2023 Jan;41(1):51-58. doi: 10.1007/s00345-022-04208-8. Epub 2022 Nov 24. World J Urol. 2023. PMID: 36434138

9

Nutritional supplementation during tuberculosis treatment to improve clinical symptoms: a double-blinded placebo-controlled randomized trial.

Yang Y, Cai J, Wang X, Zhao K, Lei Z, Han W, Yin X, Yan K, Hu Y, Zhang B, Xu L, Guo X, Xu Y, Xiong K, Gao T, Ma Y, Zhong F, Wang Q, Sun Y, Wang J, Ma A. Yang Y, et al. Among authors: xu l, xu y. Food Funct. 2025 Jan 2;16(1):102-111. doi: 10.1039/d4fo05172f. Food Funct. 2025. PMID: 39620654 Clinical Trial.

10

Prognostic Value of Dynamic Measurable Residual Disease Monitoring by Multiflowcytometry in Elderly Patients With Nonintensively Treated Acute Myeloid Leukemia.

Sun Y, Han X, Zhang Y, Fu W, Fang Y, Liu J, Xu L, Wang T, Zhong H. Sun Y, et al. Among authors: xu l. Clin Lymphoma Myeloma Leuk. 2025 Jan 2:S2152-2650(24)02470-4. doi: 10.1016/j.clml.2024.12.020. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2025. PMID: 39863462

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42,140 results

Search Page

Filters